RT Journal Article
SR Electronic
T1 Genomic characterization of Dengue virus circulation in Ethiopia
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.07.10.24310195
DO 10.1101/2024.07.10.24310195
A1 Abera, Adugna
A1 Tegally, Houriiyah
A1 Tasew, Geremew
A1 Wilkinson, Eduan
A1 Ali, Abraham
A1 Regasa, Feyisa
A1 Bitew, Molalegne
A1 Chabuka, Lucious
A1 Mwanyika, Gaspary
A1 Tshiabuila, Derek
A1 Giandhari, Jennifer
A1 Pillay, Sureshnee
A1 Poogavanan, Jenicca
A1 Moir, Monika
A1 CLIMADE Consortium
A1 Kraemer, Moritz U.G.
A1 Khan, Kamran
A1 Huber, Carmen
A1 Tollera, Getachew
A1 Wit, Tobias F. Rinke de
A1 Baxter, Cheryl
A1 Lessells, Richard
A1 Wolday, Dawit
A1 Beyene, Dereje
A1 de Oliveira, Tulio
YR 2024
UL http://medrxiv.org/content/early/2024/07/10/2024.07.10.24310195.abstract
AB In Ethiopia, dengue virus (DENV) infections have been reported in several regions, however, little is known about the circulating genetic diversity. Here, we conducted clinical surveillance for DENV during the 2023 nationwide outbreak and sequenced DENV whole genomes for the first time in Ethiopia. We enrolled patients at three sentinel hospital sites. Using RT-PCR, we screened serum samples for three arboviruses followed by serotyping and sequencing for DENV-positive samples (10.4% of samples). We detected two DENV serotypes (DENV1 and DENV3). Phylogenetic analysis identified one transmission cluster of DENV1 (genotype III major lineage A), and two clusters of DENV3 (genotype III major lineage B). The first showed close evolutionary relationship to the 2023 Italian outbreak and the second cluster to Indian isolates. Co-circulation of DENV1 and DENV3 in some regions of Ethiopia highlights the potential for severe dengue. Intensified surveillance and coordinated public health response are needed to address the threat of severe dengue outbreaks.Competing Interest StatementThe authors have declared no competing interest.Funding StatementEthiopian Public Health Institute and Addis Ababa University, KRISP and CERIAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study obtained ethical approval from Addis Ababa University (Ref. no. CNCSDO/175/15/2023), and Institutional Review Boards (IRBs) of the Ethiopian Public Health Institute (EPHI-IRB-536-2023).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll sequences used for this manuscript are publicly available on the GISAID EpiArbo database, subject to its terms and conditions (https://www.gisaid.org/), GISAID identifier: EPI_ISL_19229161 - EPI_ISL_19229193.BAMBinary Alignment MapCDCCenter for Diseases Control and preventionCERICenter for Emerging and Re-emerging Infectious diseasesCHIKVChikungunya virusCLIMADEClimate Amplified Diseases and EpidemicsCOVID-19Corona Virus Diseases-19DENVDengue virusEPHIEthiopian Public Health InstituteGISAIDGlobal initiative on sharing all influenza dataHPDHighest Posterior DensityIATAInternational Air Transport AssociationIRBInstitutional Review BoardKRISPKwaZulu-Natal Research Innovation and Sequencing PlatformMCCMaximum Clade CredibilityNCBINational Centre for Biotechnology InformationRT-PCRReverse transcription polymerase chain reactionTMRCAThe Most Common Recent AncestorZIKVZika virus